Navigating the Complexities of Intraventricular Hemorrhage in Preterm Infants: An Updated Review

Pulliahgaru Apeksha Reddy1, Himabindu Sreenivasulu2, Mohammad Shokrolahi3

  • 1Pediatric Medicine, P.E.S. Institute of Medical Sciences and Research, Kuppam, IND.

Cureus
|June 16, 2023
PubMed

Insights

Intraventricular hemorrhage (IVH) affects 12,000 US premature infants annually. This study summarizes IVH pathogenesis, diagnosis, and treatment in preterm neonates, focusing on risk factors and management.

Area of Science:

  • Neonatal Medicine
  • Pediatric Neurology
  • Medical Genetics

Background:

  • Intraventricular hemorrhage (IVH) is a critical condition in premature infants due to underdeveloped germinal matrix vasculature.
  • Approximately 12,000 premature infants in the US are diagnosed with IVH yearly, posing significant risks in neonatal intensive care units.
  • While Grades I and II IVH are common and often asymptomatic, they are associated with specific genetic mutations.

Purpose of the Study:

  • To provide a comprehensive overview of the pathogenesis, diagnosis, and treatment of intraventricular hemorrhage in premature infants.
  • To highlight the risk factors and genetic predispositions associated with IVH in neonates.
  • To discuss current diagnostic modalities and supportive management strategies for IVH.

Main Methods:

  • Literature review summarizing current data on IVH pathogenesis, incidence, and risk factors.
  • Discussion of diagnostic tools including cranial ultrasound and magnetic resonance imaging.
  • Overview of established treatment protocols for managing IVH in premature infants.

Main Results:

  • Preterm infants are highly susceptible to IVH due to germinal matrix immaturity.
  • Genetic factors like COL4A1, prothrombin G20210A, and factor V Leiden mutations are linked to Grades I and II IVH.
  • Early detection via neuroimaging within 7-14 days of birth is crucial.

Conclusions:

  • Intraventricular hemorrhage is a significant concern for premature infants, necessitating vigilant monitoring and management.
  • Supportive care, including intracranial pressure management, coagulation correction, and seizure prevention, forms the cornerstone of IVH treatment.
  • Continued research into pathogenesis and genetic links can improve outcomes for affected neonates.

Related Concept Videos

Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Increased Intracranial Pressure l: Introduction01:14

Increased Intracranial Pressure l: Introduction

Intracranial hypertension is a sustained elevation of intracranial pressure (ICP) above 22 mm Hg. In supine adults, normal ICP is ~7–15 mm Hg.The rigid, nonexpandable cranium contains three components—brain tissue, blood, and cerebrospinal fluid (CSF)—that total ~1,700 mL in a typical adult: 1,400 mL brain (~80%), 150 mL blood (~10%), and 150 mL CSF (~10%). According to the Monro–Kellie doctrine, total intracranial volume is effectively fixed. When one component expands, CSF and venous blood...
Increased Intracranial Pressure ll: Pathophysiology01:29

Increased Intracranial Pressure ll: Pathophysiology

Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...